Strategic Partnerships Lucigen is part of LGC Biosearch Technologies with active collaboration history and recent MoU agreements to integrate purification chemistries and automate workflows across global markets. Sales opportunities exist in OEM collaborations, co-developed kits, and cross-sell of purification and sequencing solutions through partner platforms.

Product Portfolio A broad catalog of over 325 biomedical research products plus expanded Epicentre offerings positions Lucigen for bundle selling, cross-sell of array-based analysis, nucleic-acid extraction, transposon mutagenesis, and next-generation sequencing prep solutions to life-science and diagnostic customers.

Quality & Compliance ISO 13485 certification signals medical-grade quality and suitability for diagnostic workflows. This enables targeting translational research labs and contract manufacturers seeking compliant kits, OEM partnerships, and regulated product lines.

Expansion Opportunities Recent expansion through acquisitions and partnerships suggests appetite for geographic and channel growth. Focus on Asia Pacific, Europe, Middle East, Canada, and Latin America markets via distributor partnerships and platform integrations to broaden customer reach.

Market Positioning Operating in the mid-market with modest revenue and a specialized NGS/sample-prep footprint, Lucigen can leverage collaborations with larger players to access bigger clinical and agricultural genomics customers, while offering cost-effective, customizable solutions to retain price-sensitive segments.